Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
A transplantable murine osteosarcoma is described. Following transplantation into a syngeneic mouse the tumor grows rapidly and kills the mouse with pulmonary metastases simulating human osteosarcoma. A cell-mediated antibody response is evoked in the host mouse as demonstrated by in vivo and in vitro tests. The number of pulmonary metastases may be decreased with adjunctive immunotherapy following excision of the primary tumor. Immunotherapeutic materials include BCG and isologous cells treated with Vibrio cholerae neuraminidase.
D000818:Animals; D000917:Antibody Formation; D001500:BCG Vaccine / Q000627:therapeutic use; D004195:Disease Models, Animal; D005260:Female; D007111:Immunity, Cellular; D007167:Immunotherapy; D007700:Kinetics; D007866:Leg; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy; D051379:Mice; D008809:Mice, Inbred C3H; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000627:therapeutic use; D012516:Osteosarcoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D012513:Sarcoma, Experimental / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D014184:Transplantation, Homologous
D001500:BCG Vaccine; D009439:Neuraminidase